GPA-500

N/A

Report date: 2025/06/11 11:06:18
NME

Base Information

Drug NameGPA-500
Drug Alias NameSTAT-3 inhibitor (glactone pharma)analog of galiellalactone (Glactone Pharma)GPA-500GPB-730
ClassificationSmall molecules
Mechanisms of ActionSignal transducer and activator of transcription 3 inhibitors
TargetsSignal transducer and activator of transcription 3
Therapy Area/IndicationsHormone-Resistant Prostate Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGlactone Pharma AB
China Registration ClassN/A

Develop Information

Active CompaniesGlactone Pharma AB
Inactive CompaniesN/A
Active IndicationsHormone-Resistant Prostate Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A